DLS

Group-IB reveals Hi-Tech Crime Trends 23/24: surge in ransomware against backdrop of growing AI, macOS threats

Retrieved on: 
Thursday, February 29, 2024

The growing appetite of nation-state sponsored threat actors, also known as advanced persistent threat (APT) groups, has shown that no region is immune to cyber threats.

Key Points: 
  • The growing appetite of nation-state sponsored threat actors, also known as advanced persistent threat (APT) groups, has shown that no region is immune to cyber threats.
  • FraudGPT and WormGPT are highly discussed tools on underground forums and Telegram channels, tailored for social engineering and phishing.
  • Group-IB's Hi-Tech Crime Trends 2023/2024 also highlighted the sale of compromised ChatGPT credentials on the dark web, building upon past research .
  • A full round-up of the top global threats and invaluable insights from the Group-IB Threat Intelligence unit can be found in the full Hi-Tech Crime Trends 2023/2024 report.

Group-IB reveals Hi-Tech Crime Trends 23/24: surge in ransomware against backdrop of growing AI, macOS threats

Retrieved on: 
Thursday, February 29, 2024

The growing appetite of nation-state sponsored threat actors, also known as advanced persistent threat (APT) groups, has shown that no region is immune to cyber threats.

Key Points: 
  • The growing appetite of nation-state sponsored threat actors, also known as advanced persistent threat (APT) groups, has shown that no region is immune to cyber threats.
  • FraudGPT and WormGPT are highly discussed tools on underground forums and Telegram channels, tailored for social engineering and phishing.
  • Group-IB's Hi-Tech Crime Trends 2023/2024 also highlighted the sale of compromised ChatGPT credentials on the dark web, building upon past research .
  • A full round-up of the top global threats and invaluable insights from the Group-IB Threat Intelligence unit can be found in the full Hi-Tech Crime Trends 2023/2024 report.

East Daley Analytics Releases 2024 Domestic Gas and Oil Industry Outlook

Retrieved on: 
Tuesday, December 12, 2023

East Daley Analytics released Dirty Little Secrets (DLS) 2024, its annual report that reveals insights into the evolving energy landscape and provides an outlook on the future dynamics of the North American oil and gas industry.

Key Points: 
  • East Daley Analytics released Dirty Little Secrets (DLS) 2024, its annual report that reveals insights into the evolving energy landscape and provides an outlook on the future dynamics of the North American oil and gas industry.
  • The report dissects the key elements shaping the industry by triangulating information across multiple commodities and combining commercial analytics, offering valuable perspectives and data-driven analyses through 2024.
  • “Current economic conditions, recent M&A activity and conflicts in the Middle East and Ukraine are leading to a volatile energy market in North America,” said Justin Carlson, Co-Founder and Chief Commercial Officer of East Daley Analytics.
  • This year’s report explores the following topics:
    Join East Daley Analytics for this webinar: Dirty Little Secrets: 2024 Domestic Oil & Gas Industry Outlook on December 13, 2023, at 10:00 am MST.

Fictiv Adds Carbon DLS™ to 3D Printing Service

Retrieved on: 
Wednesday, November 15, 2023

This new offering follows a major 3D printing service expansion giving customers access to industrial additive solutions fit for advanced engineering and high-volume production applications.

Key Points: 
  • This new offering follows a major 3D printing service expansion giving customers access to industrial additive solutions fit for advanced engineering and high-volume production applications.
  • "The trend of using 3D printing to manufacture functional, end-use parts is on the rise," said Riley Hall, Director of Additive at Fictiv.
  • "Fictiv and Carbon share a mission to help businesses develop better products and bring them to market in less time," said Phillip Desimone, CEO at Carbon.
  • To learn more about Fictiv's Carbon DLS 3D printing service,  visit the company's website .

Innate Pharma Announces New Clinical Data for Lacutamab and SAR443579/IPH6101 at ASH 2023

Retrieved on: 
Friday, November 3, 2023

Clinical Benefit Rate (CBR, defined as CR+PR+SD) was 87.5 % (n=49; 95% CI 76.4-93.8).

Key Points: 
  • Clinical Benefit Rate (CBR, defined as CR+PR+SD) was 87.5 % (n=49; 95% CI 76.4-93.8).
  • Continued evaluation of this promising new targeted treatment option for patients with Sezary Syndrome is warranted.
  • The poster will display preclinical combination data supporting anti-tumor activity and rationale for the exploration of lacutamab in combination with approved and novel therapies in patients with PTCL.
  • SAR443579 was well tolerated up to doses of 6000 μg/kg QW with observed clinical benefit in patients with R/R AML.

Latest TechTAC® Innovation Gives Operators New Flexibility in Deploying the Patented Slimline® Tubing Anchor Catcher

Retrieved on: 
Tuesday, October 3, 2023

This flexibility is made possible by the reduction in string torque rotations required to fully set the Slimline® QuickSet™ TAC.

Key Points: 
  • This flexibility is made possible by the reduction in string torque rotations required to fully set the Slimline® QuickSet™ TAC.
  • “There are tens of thousands of Slimline anchors in production today,” said Luke Reary, Operations Manager at TechTAC.
  • In contrast, the TechTAC® Slimline® Tubing Anchor Catcher can dramatically reduce that cut over time because only the slip protectors and slips need to be cut.
  • The new anchor follows the same setting procedure as TechTAC’s original Slimline® TAC but sets fully in 1-to-3 turns, as opposed to 6-to-8 turns.

Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies

Retrieved on: 
Wednesday, September 20, 2023

MILFORD, Mass., Sept. 20, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) introduces the DynaPro™ ZetaStar™ instrument from its Wyatt Technology™ portfolio for nanoparticle analysis. The new instrument simultaneously enables dynamic and static light scattering and dynamic and electrophoretic light scattering (DLS/SLS/ELS) measurements, all in one device. By combining multiple light scattering techniques and automatically assessing data quality and performing adaptive data capture, the ZetaStar instrument delivers both increased sensitivity and faster measurements to aid the precise development of complex biologics, using extremely low sample volumes.

Key Points: 
  • MILFORD, Mass., Sept. 20, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) introduces the DynaPro™ ZetaStar™ instrument from its Wyatt Technology™ portfolio for nanoparticle analysis.
  • The new instrument simultaneously enables dynamic and static light scattering and dynamic and electrophoretic light scattering (DLS/SLS/ELS) measurements, all in one device.
  • By combining multiple light scattering techniques and automatically assessing data quality and performing adaptive data capture, the ZetaStar instrument delivers both increased sensitivity and faster measurements to aid the precise development of complex biologics, using extremely low sample volumes.
  • "Developing lipid nanoparticle-based therapies that are effective and safe hinges on light scattering technologies, like those that are built in to the ZetaStar instrument.

Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies

Retrieved on: 
Wednesday, September 20, 2023

MILFORD, Mass., Sept. 20, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) introduces the DynaPro™ ZetaStar™ instrument from its Wyatt Technology™ portfolio for nanoparticle analysis. The new instrument simultaneously enables dynamic and static light scattering and dynamic and electrophoretic light scattering (DLS/SLS/ELS) measurements, all in one device. By combining multiple light scattering techniques and automatically assessing data quality and performing adaptive data capture, the ZetaStar instrument delivers both increased sensitivity and faster measurements to aid the precise development of complex biologics, using extremely low sample volumes.

Key Points: 
  • MILFORD, Mass., Sept. 20, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) introduces the DynaPro™ ZetaStar™ instrument from its Wyatt Technology™ portfolio for nanoparticle analysis.
  • The new instrument simultaneously enables dynamic and static light scattering and dynamic and electrophoretic light scattering (DLS/SLS/ELS) measurements, all in one device.
  • By combining multiple light scattering techniques and automatically assessing data quality and performing adaptive data capture, the ZetaStar instrument delivers both increased sensitivity and faster measurements to aid the precise development of complex biologics, using extremely low sample volumes.
  • "Developing lipid nanoparticle-based therapies that are effective and safe hinges on light scattering technologies, like those that are built in to the ZetaStar instrument.

OffshoreCorpTalk Achieves 250,000 Posts Milestone And Secures New Sponsorship Deal

Retrieved on: 
Sunday, September 10, 2023

London, United Kingdom--(Newsfile Corp. - September 10, 2023) - The OffshoreCorpTalk Forum has hit a milestone with 250,000 posts and is pleased to announce a new and exciting sponsorship agreement with Emirates Setup.

Key Points: 
  • London, United Kingdom--(Newsfile Corp. - September 10, 2023) - The OffshoreCorpTalk Forum has hit a milestone with 250,000 posts and is pleased to announce a new and exciting sponsorship agreement with Emirates Setup.
  • The OffshoreCorpTalk Forum has managed to reach 250,000 posts in the first week of September.
  • The constant sponsorship renewal underlined a successful collaboration, allowing both the OffshoreCorpTalk forum and DLS Dubai to find new clients.
  • Once this transition concludes, OffshoreCorpTalk expects to sign a new sponsorship deal with DLS Dubai .

Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health

Retrieved on: 
Monday, August 28, 2023

A-smart is Bionano’s second Chinese OEM partner to obtain approval from NMPA for the Company’s optical genome mapping (OGM) solutions.

Key Points: 
  • A-smart is Bionano’s second Chinese OEM partner to obtain approval from NMPA for the Company’s optical genome mapping (OGM) solutions.
  • NMPA issued two approvals to A-smart: one for Bionano’s G2 direct label and stain (DLS) DNA labeling kit and one for Bionano’s G2 SP bone marrow aspirate (BMA) DNA isolation kit.
  • A-smart received IVD Class I labels, enabling these reagents to be used for in vitro diagnostics in China.
  • Erik Holmlin, PhD, president and chief executive officer of Bionano, commented, “We want to congratulate A-smart, our second OEM partner to receive NPMA approval for our reagents.